汇宇制药(688553.SH)：“醋酸奥曲肽注射液”获得药品注册证书

智通财经APP讯，汇宇制药(688553.SH)发布公告，公司英国全资子公司Seacross Pharmaceuticals Ltd.于4月11日收到英国药品和健康产品管理局(“英国药监局”)批准核发的公司产品醋酸奥曲肽注射液《药品注册证书》，药品批准文号：PL41013/0024。

该产品主要用于肢端肥大症，胃肠胰内分泌肿瘤，预防胰腺手术后并发症以及食管/胃静脉曲张出血的治疗。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.